Skip to main content

Table 5 MIC50/90 distribution according to different resistance phenotypes

From: Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients

  Cefditoren susceptible strains Cefditoren non-susceptible strains P
Ciprofloxacin MIC50/MIC90 (mg/L) 0.012/0.032 0.19/32 <0.001
  Nalidixic acid susceptible strains Nalidixic acid non-susceptible strains P
Cefditoren MIC50/MIC90 (mg/L) 0.25/0.5 0.25/48 <0.001
  Ciprofloxacin susceptible strains Ciprofloxacin non-susceptible strains P
Cefditoren MIC50/MIC90 (mg/L) 0.25/0.5 0.5/64 <0.001